These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 29532878)

  • 1. Simvastatin exerts anticancer effects in osteosarcoma cell lines via geranylgeranylation and c-Jun activation.
    Kany S; Woschek M; Kneip N; Sturm R; Kalbitz M; Hanschen M; Relja B
    Int J Oncol; 2018 Apr; 52(4):1285-1294. PubMed ID: 29532878
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Simvastatin Reduces Cancerogenic Potential of Renal Cancer Cells via Geranylgeranyl Pyrophosphate and Mevalonate Pathway.
    Woschek M; Kneip N; Jurida K; Marzi I; Relja B
    Nutr Cancer; 2016; 68(3):420-7. PubMed ID: 27042994
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Isoprenoids responsible for protein prenylation modulate the biological effects of statins on pancreatic cancer cells.
    Gbelcová H; Rimpelová S; Knejzlík Z; Šáchová J; Kolář M; Strnad H; Repiská V; D'Acunto WC; Ruml T; Vítek L
    Lipids Health Dis; 2017 Dec; 16(1):250. PubMed ID: 29262834
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevention of Simvastatin-Induced Inhibition of Tendon Cell Proliferation and Cell Cycle Progression by Geranylgeranyl Pyrophosphate.
    Tsai WC; Yu TY; Lin LP; Cheng ML; Chen CL; Pang JH
    Toxicol Sci; 2016 Feb; 149(2):326-34. PubMed ID: 26577051
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Simvastatin-mediated enhancement of long-term potentiation is driven by farnesyl-pyrophosphate depletion and inhibition of farnesylation.
    Mans RA; McMahon LL; Li L
    Neuroscience; 2012 Jan; 202():1-9. PubMed ID: 22192838
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Simvastatin suppresses leptin expression in 3T3-L1 adipocytes via activation of the cyclic AMP-PKA pathway induced by inhibition of protein prenylation.
    Maeda T; Horiuchi N
    J Biochem; 2009 Jun; 145(6):771-81. PubMed ID: 19254925
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Simvastatin suppresses self-renewal of mouse embryonic stem cells by inhibiting RhoA geranylgeranylation.
    Lee MH; Cho YS; Han YM
    Stem Cells; 2007 Jul; 25(7):1654-63. PubMed ID: 17464088
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of isoprenylation in simvastatin-induced inhibition of ovarian theca-interstitial growth in the rat.
    Rzepczynska IJ; Piotrowski PC; Wong DH; Cress AB; Villanueva J; Duleba AJ
    Biol Reprod; 2009 Nov; 81(5):850-5. PubMed ID: 19571257
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Simvastatin decreases invasiveness of human endometrial stromal cells.
    Sokalska A; Cress A; Bruner-Tran KL; Osteen KG; Taylor HS; Ortega I; Duleba AJ
    Biol Reprod; 2012 Jul; 87(1):2, 1-6. PubMed ID: 22492974
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-tumor effects of mevalonate pathway inhibition in ovarian cancer.
    Göbel A; Zinna VM; Dell'Endice S; Jaschke N; Kuhlmann JD; Wimberger P; Rachner TD
    BMC Cancer; 2020 Jul; 20(1):703. PubMed ID: 32727400
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HMG-CoA reductase regulates CCL17-induced colon cancer cell migration via geranylgeranylation and RhoA activation.
    Al-Haidari AA; Syk I; Thorlacius H
    Biochem Biophys Res Commun; 2014 Mar; 446(1):68-72. PubMed ID: 24582560
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Simvastatin reduces lipoprotein-associated phospholipase A2 in lipopolysaccharide-stimulated human monocyte-derived macrophages through inhibition of the mevalonate-geranylgeranyl pyrophosphate-RhoA-p38 mitogen-activated protein kinase pathway.
    Song JX; Ren JY; Chen H
    J Cardiovasc Pharmacol; 2011 Feb; 57(2):213-22. PubMed ID: 21052011
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Simvastatin inhibition of mevalonate pathway induces apoptosis in human breast cancer cells via activation of JNK/CHOP/DR5 signaling pathway.
    Gopalan A; Yu W; Sanders BG; Kline K
    Cancer Lett; 2013 Feb; 329(1):9-16. PubMed ID: 22960596
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mononuclear phagocyte morphological response to chemoattractants is dependent on geranylgeranyl pyrophosphate.
    Krauklis SA; Hussain J; Murphy KM; Dray EL; Ousley CG; Justyna K; Distefano MD; Steelman AJ; McKim DB
    Am J Physiol Endocrinol Metab; 2024 Jul; 327(1):E55-E68. PubMed ID: 38717364
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evodiamine Induces Apoptosis, G2/M Cell Cycle Arrest, and Inhibition of Cell Migration and Invasion in Human Osteosarcoma Cells via Raf/MEK/ERK Signalling Pathway.
    Zhou Y; Hu J
    Med Sci Monit; 2018 Aug; 24():5874-5880. PubMed ID: 30135419
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Simvastatin Inhibits Cell Proliferation and Migration in Human Anaplastic Thyroid Cancer.
    Chen MC; Tsai YC; Tseng JH; Liou JJ; Horng S; Wen HC; Fan YC; Zhong WB; Hsu SP
    Int J Mol Sci; 2017 Dec; 18(12):. PubMed ID: 29236027
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decreased C-reactive protein-induced resistin production in human monocytes by simvastatin.
    Hu WL; Qiao SB; Li JJ
    Cytokine; 2007 Dec; 40(3):201-6. PubMed ID: 18023360
    [TBL] [Abstract][Full Text] [Related]  

  • 18. S-Adenosylmethionine Affects ERK1/2 and Stat3 Pathways and Induces Apotosis in Osteosarcoma Cells.
    Ilisso CP; Sapio L; Delle Cave D; Illiano M; Spina A; Cacciapuoti G; Naviglio S; Porcelli M
    J Cell Physiol; 2016 Feb; 231(2):428-35. PubMed ID: 26174106
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Simvastatin inhibits growth via apoptosis and the induction of cell cycle arrest in human melanoma cells.
    Saito A; Saito N; Mol W; Furukawa H; Tsutsumida A; Oyama A; Sekido M; Sasaki S; Yamamoto Y
    Melanoma Res; 2008 Apr; 18(2):85-94. PubMed ID: 18337644
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Simvastatin inhibits C-reactive protein-induced pro-inflammatory changes in endothelial cells by decreasing mevalonate pathway products.
    Liang YJ; Shyu KG; Wang BW; Lai LP
    Cardiology; 2008; 110(3):182-90. PubMed ID: 18057884
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.